α-Amyrin: A Natural Compound with Potential for Cognitive Aging

α-Amyrin: A Natural Compound with Potential for Cognitive Aging

α-Amyrin (αA), a naturally occurring compound found in a variety of fruits and vegetables, has attracted attention for its potential role in protecting against cognitive decline and neurodegeneration. A 2026 study published in Advanced Science by Shu-Qin Cao, Juan Ignacio Jiménez-Loygorri, Evandro F. Fang, Tewin Tencomnao, Patricia Boya, and their colleagues investigated the effects of αA on Alzheimer's disease-related pathology. The researchers found that αA improved spatial memory and visual recognition in mice with experimentally induced cognitive impairment. In three-dimensional human brain models, αA treatment helped prevent neuronal loss, limited astrocyte activity, and reduced levels of phosphorylated tau protein. The compound was also detected in brain tissue following intravenous administration in mice, suggesting that it can cross the blood–brain barrier. Further investigations indicated that αA may support mitochondrial health by enhancing mitochondrial respiration and mitophagy, the process through which damaged mitochondria are removed. Mechanistically, the researchers linked these effects to modulation of the DLK–SARM1–ULK1 signaling axis. αA occurs naturally in several commonly consumed fruits and vegetables, including cranberries, grapes, olives, passion fruit, sweet cherries, and tomatoes. Although these findings highlight its potential as a candidate for further research into cognitive aging, the reported results are primarily based on experimental models and do not establish its effectiveness in preventing or treating Alzheimer's disease in humans.

People are not necessarily afraid of growing old or becoming ill; what they may fear most is losing the ability to live with a clear and functioning mind. For humans, a species distinguished by its advanced cognitive abilities, one of the most concerning aspects of aging is the gradual loss of those abilities. Neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease, are prominent examples.

As anti-aging research advances, scientists are increasingly exploring not only longevity but also the preservation of cognitive function. Many compounds previously discussed in anti-aging research have also been investigated for their potential to alleviate cognitive aging. However, the natural compound α-amyrin (αA) stands out in the present study for its particularly notable effects in experimental models of cognitive decline.

1. Significant Improvements in Memory Performance

The most direct evidence of αA's potential effects came from behavioral assessments. The researchers found that αA improved memory performance in mice with experimentally induced cognitive impairment.

They first used a group of mice with impaired performance in maze-based tasks and difficulty recognizing novel objects. These tasks were used to assess spatial memory and visual recognition ability, respectively. When the mice reached approximately nine and a half months of age, they received αA treatment for two months.

The results were striking: spatial memory improved by 17.7%, while visual recognition performance increased by 25.4% in the cognitively impaired mice, bringing their performance close to that of normal mice.

Figure caption: WT refers to wild-type mice. The researchers assessed behavioral changes in mice receiving different concentrations of αA.

2. Protecting Neurons in Human Brain Models

The researchers next investigated the effects of αA at the cellular level using three-dimensional human brain models.

They found that three weeks of αA treatment helped prevent neuronal loss and limit astrocyte activity. Both neuronal loss and excessive astrocyte activation are important features associated with Alzheimer's disease.

Astrocytes are specialized cells in the central nervous system that support neuronal function and maintain the brain's local environment. Although they play essential physiological roles, their excessive activation can be associated with neuroinflammation and neurodegenerative processes.

Figure caption: αA treatment limited astrocyte migration.

3. Reduced Expression of Neurodegeneration-Associated Tau Protein

Beyond behavioral changes and cellular effects, another important indicator of neurodegeneration is tau protein. When tau accumulates abnormally and becomes excessively phosphorylated in the brain, it can contribute to the formation of neurofibrillary tangles, impair neuronal function, and participate in neurodegenerative pathology.

The researchers found that phosphorylated tau 217 (p-Tau 217) levels in the Alzheimer's disease model were 1.9 times those in the normal model. Following αA treatment, this indicator decreased by 111.7%.

Figure caption: αA significantly reduced p-Tau 217 levels in three-dimensional human brain models.

Similar changes were observed in the brains of mice receiving long-term αA treatment. In hippocampal tissue, total tau protein expression decreased by up to 50.1%, while tau phosphorylation was also substantially reduced.

Figure caption: αA reduced tau protein expression and its phosphorylation level in mouse brain tissue.

From behavioral performance to cellular changes and molecular indicators, the study provided multiple lines of experimental evidence supporting the potential of αA in research on cognitive aging. The researchers also investigated a fundamental prerequisite for compounds intended to affect the brain: the ability to cross the blood–brain barrier.

Many compounds may theoretically have beneficial effects on cognitive function, but their potential can be limited if they cannot reach the brain. The blood–brain barrier restricts the passage of many substances from the bloodstream into brain tissue.

αA, however, was detected in the brain following intravenous administration in mice. After an intravenous dose of 10 mg/kg body weight, the concentration of αA in brain samples reached 20.1 ng/mL at two hours and peaked at 34.3 ng/mL at eight hours. These findings indicate that αA can reach brain tissue under the experimental conditions used in this study.

Figure caption: αA crossed the blood–brain barrier and reached mouse brain tissue.

The Mechanism Behind αA's Potential Anti-Aging Effects: Mitochondrial Health

Although the cognitive findings were promising, understanding the underlying molecular mechanisms was essential for a more complete interpretation of αA's effects. The researchers therefore investigated how the compound might influence the biological processes associated with neurodegeneration.

Their findings pointed to mitochondrial health as a central part of αA's potential protective mechanism.

Mitochondria are essential cellular organelles responsible for energy production and other physiological processes. Previous research has identified mitochondrial dysfunction as an important feature associated with neuronal damage and Alzheimer's disease. In the present study, the researchers also found that the number of damaged mitochondria in the hippocampus of cognitively impaired mice was twice that observed in normal mice.

Following αA treatment, the mitochondria in the brains of these mice recovered a more normal size and shape. In addition, 42.8% of the previously damaged mitochondria were cleared.

Figure caption: αA promoted the clearance of damaged mitochondria in the brains of cognitively impaired mice, bringing mitochondrial characteristics closer to those observed in normal mice.

To further investigate these effects, the researchers examined ARPE-19 cells, a human retinal pigment epithelial cell line with substantial metabolic activity and a strong dependence on mitochondrial function.

The results showed that αA increased several indicators of mitochondrial performance. Specifically, it increased basal oxygen consumption by 22.2%, ATP production by 18.6%, maximal respiration by 50%, spare respiratory capacity by 22.8%, and mitophagy by approximately 50%.

These findings suggest that αA enhanced multiple aspects of mitochondrial function, including baseline energy metabolism and the capacity to respond to increased metabolic demands.

Figure caption: αA improved mitochondrial function and mitophagy in human cells and mice.

Further mechanistic investigations indicated that αA acted by inhibiting the activity of the key intracellular molecule DLK. This relieved the restraint imposed by SARM1 on ULK1, a core regulator of autophagy, allowing ULK1 to become activated and initiate mitophagy. Through this pathway, damaged mitochondria could be identified and removed.

This signaling pathway, known as the DLK–SARM1–ULK1 axis, provides a mechanistic explanation for how αA may support mitochondrial quality control and, potentially, help protect against processes associated with neurodegeneration.

What Is α-Amyrin, and Where Is It Found?

At this point, the study had explored αA's potential effects on cognitive performance, neuronal health, tau pathology, and mitochondrial function. But what exactly is αA, and why did the researchers select this relatively little-known natural compound for their investigation?

The starting point was a familiar observation: eating more fruits and vegetables is associated with better health, including better cognitive health.

Figure caption: Greater fruit and vegetable consumption has been associated with a lower risk of neurodegenerative diseases.

To investigate which compounds in fruits and vegetables might contribute to human health and longevity, the researchers screened a database covering a broad range of these foods. They then selected αA from ten candidates identified as being particularly relevant to health and longevity. At the time of the study, αA had received relatively little attention and had not yet been commercialized as a widely established ingredient. The researchers subsequently investigated its potential in experimental models, obtaining encouraging results.

Despite its relatively low profile, αA occurs naturally in a range of familiar fruits and vegetables, including American cranberries, Asian pears, sweet peppers, eggplants, European cranberries, grapes, olives, passion fruit, sweet cherries, and tomatoes. Particularly in ripe passion fruit and olives, αA is present not only in the flesh but also in the peel.

Beyond research into aging, αA has also been investigated for a range of other biological activities, including anti-inflammatory, antidiabetic, anti-atherosclerotic, analgesic, antigout, antibacterial, and anti-HIV activities.

A relatively little-known natural compound found in a variety of fruits and vegetables has therefore emerged as a subject of broad scientific interest. Nature often contains unexpected compounds with potentially important biological properties. Quercetin and other flavonoids are examples of natural substances that have attracted considerable attention in health research, and αA is now another compound worth investigating.

The findings of this study offer an interesting direction for future research into cognitive aging and longevity. However, it is important to distinguish experimental findings from demonstrated human health benefits. The observed improvements in memory, changes in tau pathology, and effects on mitochondrial function do not yet establish that consuming αA-rich foods or taking αA supplements can prevent or treat Alzheimer's disease. Further research, particularly well-designed human clinical trials, will be needed to determine its safety, effective dosage, bioavailability, and potential applications in human health.

References

[1] Cao, S. Q., Jiménez-Loygorri, J. I., Qiu, Y., Kang, Y. J., Do, K. V., Smith, A. E., Huang, J., Pan, J. P., Mao, L., Li, A., Yang, H., Aman, Y., Lagartos, M. J. D., Lautrup, S. H., Chen, A., Liang, K. X., Zhang, H., Yi, J., Jin, X., Cheung, T. C., … Fang, E. F. (2026). The Mitochondrial Guardian α-Amyrin Mitigates Alzheimer's Disease Pathology via Modulation of the DLK-SARM1-ULK1 Axis. Advanced Science (Weinheim, Baden-Württemberg, Germany), e12374. Advance online publication. https://doi.org/10.1002/advs.202512374

[2] Quirós-Cubillo, M., Valdés-Díaz, S., Oviedo-Quirós, J., Álvarez-Valverde, V., & Syedd-León, R. (2025). Antioxidant and Antibacterial Potential of Passiflora edulis (Passion Fruit) at Three Ripening Stages for Waste Valorization. Molecules, 30(17), 3454. https://doi.org/10.3390/molecules30173454

[3] Cao, S. Q., Aman, Y., Fang, E. F., & Tencomnao, T. (2022). P. edulis Extract Protects Against Amyloid-β Toxicity in Alzheimer's Disease Models Through Maintenance of Mitochondrial Homeostasis via the FOXO3/DAF-16 Pathway. Molecular Neurobiology, 59(9), 5612–5629. https://doi.org/10.1007/s12035-022-02904-5

[4] Viet, T. D., Anh, L. H., Xuan, T. D., & Dong, N. D. (2025). The Pharmaceutical Potential of α- and β-Amyrins. Nutraceuticals, 5(3), 21. https://doi.org/10.3390/nutraceuticals5030021

Zurück zum Blog